scorecardresearch Skip to main content

More Life Sciences Headlines

Vertex scientists share $3 million prize for developing the company’s cystic fibrosis drugs

Their work has dramatically extended the life expectancy of CF patients.

Generate Biomedicines raises $273 million in latest round of funding

The money arrives amid a slump in biotech investments this year, as investors stick to the sidelines because of economic uncertainty and interest rate hikes.

FDA advisers are lukewarm about expanding use of Alnylam drug to heart patients

The experts agreed with FDA scientists that the benefits to patients in a clinical trial compared to a placebo were modest at best.


CVS, Walgreens illegally marketed ‘unapproved’ eye drops, FDA says

CVS and Walgreens claim to have stopped selling the eye drops, and consumers who previously purchased them can get full refunds.

Moderna poised to seek flu shot approval after trial results

In a trial on over 2,400 adults, the reformulated shot produced a stronger immune response against all four strains of the influenza virus than a traditional flu vaccine, the company said in a statement Wednesday.

Cambridge biotech 2Seventy Bio slashes 40 percent of workforce

The job cuts are the latest in a series of layoffs in the biopharmaceutical industry.

Neumora seeks to become the second Massachusetts biotech to go public in 2023

Neumora hopes to raise up to $265 million from investors, leaving it with a market value of as much as $2.7 billion.

FDA clears drug to help harvest stem cells to treat multiple myeloma patients

The injectable will be sold by an Israeli biotech BioLineRx, which has its US headquarters in Waltham.